| Financial Year |
March 31 2023 |
| Monetary Funds |
5,650,265,454.12 |
| Held-for-trading Financial Assets |
185,394,300.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
960,371,545.26 |
| Advances to Suppliers |
2,001,942,983.26 |
| Other Receivables |
177,795,707.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,221,001,740.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
111,130,905.77 |
| Total Current Assets |
14,434,717,352.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
184,966,630.96 |
| Investment Properties |
33,605,337.60 |
| Fixed Assetes |
1,035,828,373.43 |
| Under-construction Projects |
139,064,301.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
526,568,568.47 |
| R&D expenses |
-- |
| Goodwill |
407,845,786.45 |
| Long-Term Deferred and Prepaid Expenses |
289,086,394.50 |
| Deferred Income Tax Assets |
192,624,095.67 |
| Other Non-Current Assets |
8,658,281.49 |
| Sub-Total of Non-Current Assets |
4,204,016,055.55 |
| Total Assets |
18,638,733,408.29 |
| Short-Term Loans |
2,527,690,854.93 |
| Trading Financial liabilities |
26,000.00 |
| Notes Payable |
2,829,934,897.82 |
| Accounts Payable |
1,431,964,369.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
280,278,014.19 |
| Taxes Payable |
160,641,421.11 |
| Interest Payable |
-- |
| Dividend Payable |
117,600,000.00 |
| Other payables |
575,435,868.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
57,840,739.29 |
| Other Current Liabilities |
217,865,736.67 |
| Sub-Total of Current Liabilities |
10,962,706,460.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
8,499,327.20 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
299,315,924.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
722,261,770.55 |
| Total Liabilities |
11,684,968,231.03 |
| Paid-In Capital(Or Share Stock) |
522,515,799.00 |
| Capital Surplus |
825,038,348.47 |
| Surplus Reserve |
71,209,717.03 |
| LESS:Treasury Stock |
60,420,000.00 |
| Undistributed Profits |
2,839,178,236.44 |
| Minority Stockholder's Interest |
2,552,829,447.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,400,935,729.51 |
| Owner's Equity（Stockholder's Equity） |
6,953,765,177.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,638,733,408.29 |
